Patent ID: 9289419
Filing Date: 2016-03-22
CPC Classification: A61K,A61P,C07D,Y02A

Claim Text:
1. A method of treating diseases associated with the TrkA kinase activity by administering effective amount of a compound having the formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates or stereoisomers thereof, wherein R R wherein when R R R R R R R R R alternatively R R R R R R R m is independently selected from 0, 1, 2, 3 or 4; n is independently selected from 1, 2, 3 or 4; and p is 0, 1, 2, 3 or 4, wherein the disease is selected from the group consisting of pain, cancer, psoriasis, psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, atopic dermatitis, fibrosis, neurodegenerative disease, and Trypanosoma Cruzi infection.